Literature DB >> 19712053

Context-dependent IL-6 potentiation of interferon- gamma-induced IL-12 secretion and CD40 expression in murine microglia.

Hsiao-Wen Lin1, Steven W Levison.   

Abstract

Interleukin-6 (IL-6) is produced by neurons, astrocytes, and microglia, and elevated levels of IL-6 within the CNS have been documented in multiple neurological disorders including Alzheimer's disease, stroke, epilepsy, attention deficit disorder, cerebral palsy, and multiple sclerosis. Here, we sought to understand how IL-6 regulates microglial signal transduction and their immune properties. Using highly enriched cultures of neonatal murine microglia we show that IL-6 alone has direct effects on microglia as it activates STAT3 and extracellular signal-regulated kinase pathways in a time- and dose-dependent fashion and it enhances interferon-gamma (IFNgamma)-stimulated IL-12 secretion. However, other immune properties were only weakly modulated by IL-6 when administered without the soluble IL-6 receptor (sIL-6R). For instance, IFNgamma-induced expression of the co-stimulatory molecule, CD40 was dependent on sIL-6R administration. IL-6 with or without sIL-6R did not affect major histocompatability complex class II expression. In granulocyte-macrophage colony-stimulating factor (GMCSF)-induced dendritic cell-like microglia, IL-6/sIL-6R and IFNgamma stimulated an even greater increase in CD40 expression compared with primary microglia. Altogether, our results demonstrate that microglial responses to IL-6 are not simple in that the effects of IL-6 are context-dependent. In particular, the presence or absence of sIL-6R, IFNgamma or GMCSF will alter the type and amplitude of their response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19712053     DOI: 10.1111/j.1471-4159.2009.06366.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

Review 1.  Immunoinflammatory diseases of the central nervous system - the tale of two cytokines.

Authors:  M J Hofer; I L Campbell
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

2.  Decreased Methylation Level of H3K27me3 Increases Seizure Susceptibility.

Authors:  Zhongcheng Wang; Yusong Zhang; Jian Fang; Fang Yu; Duanhe Heng; Yuanteng Fan; Jian Xu; Biwen Peng; Wanhong Liu; Song Han; Xiaohua He
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

Review 3.  Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS.

Authors:  Tobias D Merson; Michele D Binder; Trevor J Kilpatrick
Journal:  Neuromolecular Med       Date:  2010-03-30       Impact factor: 3.843

4.  Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain.

Authors:  Iain L Campbell; Maria Erta; Sue Ling Lim; Ricardo Frausto; Ulrike May; Stefan Rose-John; Jürgen Scheller; Juan Hidalgo
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

5.  A common carcinogen benzo[a]pyrene causes neuronal death in mouse via microglial activation.

Authors:  Kallol Dutta; Debapriya Ghosh; Arshed Nazmi; Kanhaiya Lal Kumawat; Anirban Basu
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

6.  Ambivalent effects of compound C (dorsomorphin) on inflammatory response in LPS-stimulated rat primary microglial cultures.

Authors:  Krzysztof Labuzek; Sebastian Liber; Bozena Gabryel; Lukasz Bułdak; Bogusław Okopień
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-26       Impact factor: 3.000

7.  Involvement of Spinal IL-6 Trans-Signaling in the Induction of Hyperexcitability of Deep Dorsal Horn Neurons by Spinal Tumor Necrosis Factor-Alpha.

Authors:  Christian König; Eric Morch; Annett Eitner; Christian Möller; Brian Turnquist; Hans-Georg Schaible; Andrea Ebersberger
Journal:  J Neurosci       Date:  2016-09-21       Impact factor: 6.167

8.  Interleukin-6 is both necessary and sufficient to produce perioperative neurocognitive disorder in mice.

Authors:  J Hu; X Feng; M Valdearcos; D Lutrin; Y Uchida; S K Koliwad; M Maze
Journal:  Br J Anaesth       Date:  2018-02-03       Impact factor: 9.166

9.  CX3CR1 RNAi inhibits hypoxia-induced microglia activation via p38MAPK/PKC pathway.

Authors:  Yong Liu; Tianzhi Zhao; Zhao Yang; Qianning Li
Journal:  Int J Exp Pathol       Date:  2014-04       Impact factor: 1.925

Review 10.  Therapeutic Potential of Cytokines in Demyelinating Lesions After Stroke.

Authors:  Yi-Sha Guo; Mei Yuan; Yu Han; Xin-Ya Shen; Zhen-Kun Gao; Xia Bi
Journal:  J Mol Neurosci       Date:  2021-05-10       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.